Scheer Rowlett & Associates Investment Management’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.7M Sell
287,859
-170,672
-37% -$12.2M 1.56% 23
2025
Q4
$28.3M Sell
458,531
-145,207
-24% -$8.55M 1.94% 20
2025
Q3
$35.4M Sell
603,738
-10,788
-2% -$629K 2.11% 19
2025
Q2
$35.8M Buy
614,526
+16,309
+3% +$922K 2.32% 18
2025
Q1
$29.7M Sell
598,217
-73,772
-11% -$3.77M 2.2% 19
2024
Q4
$30M Buy
671,989
+69,266
+11% +$3.29M 2.19% 20
2024
Q3
$29M Sell
602,723
-5,852
-1% -$282K 2.02% 21
2024
Q2
$31M Sell
608,575
-4,230
-0.7% -$232K 2.37% 19
2024
Q1
$33.3M Buy
612,805
+85,852
+16% +$4.48M 2.46% 20
2023
Q4
$29.7M Sell
526,953
-9,749
-2% -$551K 2.24% 20
2023
Q3
$33.1M Sell
536,702
-9,044
-2% -$572K 2.8% 17
2023
Q2
$32.2M Buy
545,746
+17,745
+3% +$1.13M 2.58% 18
2023
Q1
$39M Sell
528,001
-4,031
-0.8% -$311K 3.23% 16
2022
Q4
$38.8M Sell
532,032
-6,990
-1% -$552K 3.24% 13
2022
Q3
$44.9M Sell
539,022
-17,329
-3% -$1.49M 4.06% 10
2022
Q2
$44.3M Sell
556,351
-21,040
-4% -$2.04M 3.51% 11
2022
Q1
$59.7M Sell
577,391
-319,870
-36% -$26.5M 3.91% 11
2021
Q4
$67.5M Sell
897,261
-157,960
-15% -$11.1M 4.64% 7
2021
Q3
$68.4M Buy
1,055,221
+12,134
+1% +$742K 4.86% 7
2021
Q2
$63.2M Buy
1,043,087
+139,044
+15% +$8.23M 4.57% 8
2021
Q1
$48.7M Sell
904,043
-45,260
-5% -$2.46M 3.74% 12
2020
Q4
$45.7M Sell
949,303
-32,610
-3% -$1.44M 3.53% 12
2020
Q3
$38.5M Sell
981,913
-6,440
-0.7% -$234K 3.39% 15
2020
Q2
$31.8M Sell
988,353
-17,863
-2% -$622K 2.87% 16
2020
Q1
$34.4M Sell
1,006,216
-167,630
-14% -$6.71M 3.47% 14
2019
Q4
$56.3M Buy
1,173,846
+51,380
+5% +$2.48M 4.15% 9
2019
Q3
$56M Sell
1,122,466
-124,604
-10% -$6.36M 4.32% 8
2019
Q2
$66.9M Sell
1,247,070
-260,294
-17% -$13.6M 4.58% 7
2019
Q1
$79.5M Sell
1,507,364
-110,043
-7% -$5.73M 5.55% 6
2018
Q4
$75.9M Sell
1,617,407
-93,967
-5% -$4.9M 5.85% 6
2018
Q3
$98.7M Buy
1,711,374
+8,814
+0.5% +$488K 6.29% 6
2018
Q2
$92.6M Buy
1,702,560
+61,755
+4% +$3.06M 5.79% 6
2018
Q1
$77.5M Buy
+1,640,805
New +$82.2M 4.95% 6

Other funds holding NTR

Scheer Rowlett & Associates Investment Management's NTR Position: Q1 2026 in Review

Scheer Rowlett & Associates Investment Management reduced its Nutrien (NTR) stake by 37% in Q1 2026, selling an estimated $12.2M and leaving 287,859 shares worth $21.7M. The position accounts for 1.56% of the portfolio, ranked #23.

Scheer Rowlett & Associates Investment Management first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $98.7M in Q3 2018. 748 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Scheer Rowlett & Associates Investment Management held 287,859 shares of Nutrien worth $21.7M as of Q1 2026.
  • Scheer Rowlett & Associates Investment Management sold 170,672 Nutrien shares in Q1 2026, an estimated $12.2M.
  • Nutrien made up 1.56% of Scheer Rowlett & Associates Investment Management's portfolio in Q1 2026, its #23 holding.
  • Scheer Rowlett & Associates Investment Management first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
  • Scheer Rowlett & Associates Investment Management's Nutrien position peaked at $98.7M in Q3 2018.
  • 748 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Scheer Rowlett & Associates Investment Management's 13F filing for Q1 2026, filed 11 May 2026.